All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
As a leading cell therapy biotechnology company, Creative Biolabs provides one-stop CAR-T therapy development services, ranging from GMP/GLP-graded CAR plasmid production (providing mg-level to g-level production scale), GMP-graded CAR lentivirus production, to CAR -T cell production to meet the needs of non-clinical research and clinical phase I trials initiated by cellular therapy researchers.
Understanding each step of the CAR-T workflow is essential to ensure the quality and effectiveness of the final CAR-T product. An Ideally panel for new CAR-T development and QC, the CAR-T generation cell line characterization panel can help simplify the CAR-T manufacturing workflow and potentially reduce vein to vein time. Besides, contaminant-free cell banks lay a solid foundation for you to maintain a stable production path in the next few years. Therefore, proper cell line characterization is critical to confirm the certainty of the contamination-free cell bank. Creative Biolabs offers a wide range of CAR-T cell line characterization services, including phenotypic or genotypic identity testing, which is required for mammalian, microbial, and insect cell substrate testing to generate CAR-T cells.
The characterization of CAR-T cell lines mainly involves the following cell lines:
More specifically, the characterization of CAR-T cell lines is to perform cell lines on the main cell bank (MCB), working cell bank (WCB) used for production. According to current regulations, the following aspects must be considered:
When executing the assays, Creative Biolabs follows the guidelines recommend and using testing procedures that are validated to show their suitability for intended CAR-T purpose.
Advanced Analysis Modules Available for CAR-T Cell Line Characterization
The following table lists the recommended test panels for characterizing general mammalian and microbial cell lines used to produce CAR-T, as well as T cells.
Recommended Testing Items | MCB | WCB |
Bacteriophage detection | + | + |
Purity | + | + |
Identification | + | + |
Viability | + | + |
Copy number | + | + |
DNA Sequencing | + | + |
Retention of selectable markers | + | + |
Retention of recombinant construct | + | + |
Restriction Endonuclease Analysis | + | + |
Recommended Testing Items | MCB | WCB | EPC/CAL | |
Microbial Contamination | Sterility | + | + | + |
Mycoplasma | + | + | + | |
Mycobacterium | + | |||
Spiroplasma | + | |||
Cell Line Identity | DNA Barcoding | + | + | + |
DNA fingerprinting/STR | + | + | ||
Karyology | + | + | ||
Genetic stability | DNA sequencing | + | Optional | |
Gene copy number by qPCR/STR | + | + | ||
Virus Testing | Retroviruses: Reverse transcriptase and retroviral infectivity assays | + | + | |
In vitro adventitious viruses | + | + | + | |
In vivo adventitious viruses | + | + | ||
Test for specific viruses such as: Bovine viruses Porcine viruses Human viruses Minute virus of mice |
+ | |||
In vivo biosafety: Mouse, hamster, and rat antibody production assays (MAP, RAP, and HAP) | + | |||
Transmission electron microscopy | + | + | ||
Tumorigenicity/Oncogenicity | + |
Recommended Testing Items | MCB | WCB | EPC/CAL | |
Microbial Contamination | Sterility | + | + | + |
Mycoplasma | + | + | + | |
SV40 Large T Antigen Sequence Analysis | + | + | + | |
Cell Line Identity | DNA Barcoding | + | + | + |
Genetic stability | DNA sequencing | + | + | |
Gene copy number | + | + | ||
Restriction endonuclease analysis | + | + | ||
Virus Testing | Endogenous and non-endogenous retroviruses: reverse transcriptase and retroviral infectivity assays | + | + | |
In vitro adventitious viruses | + | + | ||
In vivo adventitious viruses (suckling and adult mice, embryonated eggs) | + | + | ||
Test for specific viruses such as: Bovine viruses Porcine viruses Minute virus of mice |
+ | |||
In vivo biosafety: Mouse and hamster antibody production assays (MAP and HAP) | + | |||
Transmission electron microscopy | + | + |
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION